Free Trial

Grown Rogue International (OTCMKTS:GRUSF) Issues Quarterly Earnings Results

Grown Rogue International logo with Medical background

Grown Rogue International (OTCMKTS:GRUSF - Get Free Report) posted its quarterly earnings results on Monday. The company reported $0.01 earnings per share (EPS) for the quarter, Zacks reports. The firm had revenue of $5.65 million for the quarter.

Grown Rogue International Price Performance

OTCMKTS:GRUSF traded down $0.01 during mid-day trading on Friday, hitting $0.35. The stock had a trading volume of 554,519 shares, compared to its average volume of 218,697. The company's 50 day simple moving average is $0.55 and its 200 day simple moving average is $0.63. The company has a current ratio of 0.90, a quick ratio of 0.63 and a debt-to-equity ratio of 0.12. Grown Rogue International has a twelve month low of $0.32 and a twelve month high of $0.90.

Grown Rogue International Company Profile

(Get Free Report)

Grown Rogue International Inc, together with its subsidiaries, produces and sells cannabis products in the United States. It offers a range of cultivars for consumers, such as indicas, sativas, and hybrids; strain-specific prepackaged flowers; and pre-roll pack products, as well as provides consulting services.

See Also

Earnings History for Grown Rogue International (OTCMKTS:GRUSF)

Should You Invest $1,000 in Grown Rogue International Right Now?

Before you consider Grown Rogue International, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grown Rogue International wasn't on the list.

While Grown Rogue International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market
Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines